Cargando…
Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine
Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516165/ https://www.ncbi.nlm.nih.gov/pubmed/33013395 http://dx.doi.org/10.3389/fphar.2020.556885 |
_version_ | 1783586948031447040 |
---|---|
author | Luo, Chuan-hong Ma, Le-le Liu, Hui-min Liao, Wei Xu, Run-chun Ci, Zhi-min Lin, Jun-zhi Han, Li Zhang, Ding-kun |
author_facet | Luo, Chuan-hong Ma, Le-le Liu, Hui-min Liao, Wei Xu, Run-chun Ci, Zhi-min Lin, Jun-zhi Han, Li Zhang, Ding-kun |
author_sort | Luo, Chuan-hong |
collection | PubMed |
description | Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rather than fever in the early stage. Many herbal medicine and Chinese patent medicine can significantly improve these symptoms, cure the patients experiencing a mild 22form of the illness, reduce the rate of transition from mild to severe disease, and reduce mortality. Therefore, this paper summarizes the physiopathological mechanisms of fever, cough, fatigue and diarrhea, and introduces Chinese herbal medicines (Ephedrae Herba, Gypsum Fibrosum, Glycyrrhizae Radix et Rhizoma, Asteris Radix et Rhizoma, Ginseng Radix et Rhizoma, Codonopsis Radix, Atractylodis Rhizoma, etc.) and Chinese patent medicines (Shuang-huang-lian, Ma-xing-gan-shi-tang, etc.) with their corresponding therapeutic effects. Emphasis was placed on their material basis, mechanism of action, and clinical research. Most of these medicines possess the pharmacological activities of anti-inflammatory, antioxidant, antiviral, and immunity-enhancement, and may be promising medicines for the treatment or adjuvant treatment of COVID-19 patients. |
format | Online Article Text |
id | pubmed-7516165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75161652020-10-02 Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine Luo, Chuan-hong Ma, Le-le Liu, Hui-min Liao, Wei Xu, Run-chun Ci, Zhi-min Lin, Jun-zhi Han, Li Zhang, Ding-kun Front Pharmacol Pharmacology Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rather than fever in the early stage. Many herbal medicine and Chinese patent medicine can significantly improve these symptoms, cure the patients experiencing a mild 22form of the illness, reduce the rate of transition from mild to severe disease, and reduce mortality. Therefore, this paper summarizes the physiopathological mechanisms of fever, cough, fatigue and diarrhea, and introduces Chinese herbal medicines (Ephedrae Herba, Gypsum Fibrosum, Glycyrrhizae Radix et Rhizoma, Asteris Radix et Rhizoma, Ginseng Radix et Rhizoma, Codonopsis Radix, Atractylodis Rhizoma, etc.) and Chinese patent medicines (Shuang-huang-lian, Ma-xing-gan-shi-tang, etc.) with their corresponding therapeutic effects. Emphasis was placed on their material basis, mechanism of action, and clinical research. Most of these medicines possess the pharmacological activities of anti-inflammatory, antioxidant, antiviral, and immunity-enhancement, and may be promising medicines for the treatment or adjuvant treatment of COVID-19 patients. Frontiers Media S.A. 2020-09-11 /pmc/articles/PMC7516165/ /pubmed/33013395 http://dx.doi.org/10.3389/fphar.2020.556885 Text en Copyright © 2020 Luo, Ma, Liu, Liao, Xu, Ci, Lin, Han and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Luo, Chuan-hong Ma, Le-le Liu, Hui-min Liao, Wei Xu, Run-chun Ci, Zhi-min Lin, Jun-zhi Han, Li Zhang, Ding-kun Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title | Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title_full | Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title_fullStr | Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title_full_unstemmed | Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title_short | Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
title_sort | research progress on main symptoms of novel coronavirus pneumonia improved by traditional chinese medicine |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516165/ https://www.ncbi.nlm.nih.gov/pubmed/33013395 http://dx.doi.org/10.3389/fphar.2020.556885 |
work_keys_str_mv | AT luochuanhong researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT malele researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT liuhuimin researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT liaowei researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT xurunchun researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT cizhimin researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT linjunzhi researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT hanli researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine AT zhangdingkun researchprogressonmainsymptomsofnovelcoronaviruspneumoniaimprovedbytraditionalchinesemedicine |